Long-Term Prognosis in Heart Failure: Findings From the Ten-Year Follow-Up of the Trivandrum Registry
Journal of Cardiac Failure · 2026-08
DOI: 10.1016/j.cardfail.2026.07.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2026-08. Verfasst von Sivadasanpillai Harikrishnan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India. Electronic address: drharikrishnan@outlook.com. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Indian Council of Medical Research.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND AND METHODS: The Trivandrum Heart Failure Registry (THFR) is a prospective cohort study of patients hospitalized with acute decompensated heart failure (HF) in 18 hospitals across Trivandrum, Kerala, from January to December 2013. Trained nurses collected detailed clinical and treatment data, and participants were followed every 3-6 months for 10 years. We used Kaplan-Meier survival curves and the Cox proportional hazards model to analyze factors associated with mortality in HF. RESULTS: A total of 1,205 patients were enrolled (mean age 61.2 ± 13.6 years), with a male predominance (n = 834, 69%). The majority (n = 752, 62.4%) had heart failure with reduced ejection fraction (HFrEF), 21.8% had mildly reduced EF (HFmrEF), and 15.8% had preserved EF (HFpEF). Comorbid conditions were common, with 55% having diabetes and 58% hypertension. Ischemic heart disease was the leading cause of HF (71.9%), followed by dilated cardiomyopathy (12.9%) and rheumatic heart disease (7.9%). At discharge, only 25.4% of HFrEF patients received guideline-directed medical therapy (GDMT), a combination of an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker, a beta-blocker, and a mineralocorticoid receptor antagonist. Complete follow-up data were available for 88.8% of participants. The overall mortality at 10 years was 875 (82.7%) of 1,058 patients available for follow-up, with cardiovascular causes accounting for 838 (96%) of deaths; the remainder were attributed to COVID-19 and other non-cardiovascular conditions. Mortality was highest among those with HFrEF (85.3%), followed by HFmrEF (82.1%) and HFpEF (72.7%) (log-rank P < .001). Among patients with HFrEF on follow-up, the mortality was 126 (75.9%) for those prescribed GDMT at baseline, compared with 437 (88.6%) for those not prescribed GDMT (HR = 0.71; 95% CI 0.57-0.88, P = .002). CONCLUSIONS: In this Indian HF registry, 83% of patients died over 10 years, reflecting high mortality. GDMT for HFrEF showed lasting survival benefits, while patients with HFpEF had lower mortality than HFrEF and HFmrEF. The findings stress the need for better implementation of GDMT and wider preventive strategies to reduce HF burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India. Electronic address: drharikrishnan@outlook.com.
- Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
- Division of Cardiology, Washington University in St Louis School of Medicine, St. Louis, Missouri; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Bursky School…
- Division of Cardiology, Washington University in St Louis School of Medicine, St. Louis, Missouri.
- Medical College Hospital, Trivandrum, Kerala, India.
- NIMS Hospital, Neyyattinkara, Trivandrum, Kerala, India.
Förderung
- NHLBI NIH HHS
- Indian Council of Medical Research
Zitieren
APA
Harikrishnan, S., Ganapathi, S., Huffman, M. D., Agarwal, A., Viswanathan, S., Sreedharan, M., Vijayaraghavan, G., Bahuleyan, C. G., Biju, R., Nair, T., Pratapkumar, N., Krishnakumar, K., Rajalekshmi, N., Suresh, K., Sarma, M., Safvan, K., Rajamoni, K., & Jeemon, P. (2026). Long-Term Prognosis in Heart Failure: Findings From the Ten-Year Follow-Up of the Trivandrum Registry. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2026.07.028
Vancouver
Harikrishnan S, Ganapathi S, Huffman MD, Agarwal A, Viswanathan S, Sreedharan M, et al. Long-Term Prognosis in Heart Failure: Findings From the Ten-Year Follow-Up of the Trivandrum Registry. Journal of Cardiac Failure. 2026. doi:10.1016/j.cardfail.2026.07.028
BibTeX
@article{Harikrishnan2026,
author = {Harikrishnan, Sivadasanpillai and Ganapathi, Sanjay and Huffman, Mark D and Agarwal, Anubha and Viswanathan, Sunitha and Sreedharan, Madhu and Vijayaraghavan, Govindan and Bahuleyan, Charantharayil G and Biju, Ramabhadran and Nair, Tiny and Pratapkumar, N and Krishnakumar, K and Rajalekshmi, N and Suresh, Krishnan and Sarma, Meenakshi and Safvan, Karkuzhiyil and Rajamoni, Kochumoni and Jeemon, Panniyammakal},
title = {Long-Term Prognosis in Heart Failure: Findings From the Ten-Year Follow-Up of the Trivandrum Registry},
journal = {Journal of Cardiac Failure},
year = {2026},
doi = {10.1016/j.cardfail.2026.07.028}
}
EUVIMED